0001593968-20-001745.txt : 20200813
0001593968-20-001745.hdr.sgml : 20200813
20200813171942
ACCESSION NUMBER: 0001593968-20-001745
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200813
FILED AS OF DATE: 20200813
DATE AS OF CHANGE: 20200813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller-Rich Nancy
CENTRAL INDEX KEY: 0001735084
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37841
FILM NUMBER: 201100302
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 10 HUDSON YARDS, 37TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kadmon Holdings, Inc.
CENTRAL INDEX KEY: 0001557142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273576929
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-308-6000
MAIL ADDRESS:
STREET 1: 450 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Kadmon Holdings, LLC
DATE OF NAME CHANGE: 20120829
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2020-08-13
0001557142
Kadmon Holdings, Inc.
KDMN
0001735084
Miller-Rich Nancy
C/O KADMON HOLDINGS, INC.
450 E. 29TH STREET
NEW YORK
NY
10016
true
false
false
false
Stock Option (right to buy)
4.17
2020-08-13
4
A
false
36364
4.17
A
2030-08-13
Common stock, $0.001 par value
36364
36364
D
The option vests and becomes exercisable in three equal annual installments over 3 years from August 13, 2020, the date of grant.
Only represents derivative securities of this class.
/s/ Gregory S. Moss, Attorney-in-Fact
2020-08-13